In Vivo and in Vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 1368-1375

  Young, Steven L ^a,g   Lessey, Bruce A ^c   Fritz, Marc A ^c   Meyer, William R ^c   Murray, Michael J ^d,e   Speckman, Paul L ^b   Nowicki, Bogdan J ^f  

^a Departments of Obstet/Gynecology   (United States)

^b Department of Statistics ^*  (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f University of Texas Medical Branch School of Medicine   (United States)

^g University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LUTEINIZING HORMONE; MESSENGER RNA; MONOCLONAL ANTIBODY; PROGESTERONE; RECEPTOR SUBTYPE;

APICAL MEMBRANE; ARTICLE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; DOSE RESPONSE; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; FEMALE FERTILITY; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0036962167     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.3.8350     Document Type: Article

References (41)

1. Roitt I, Brostoff J, Male D 1998 Immunology. London: Mosby
2. Carroll MC, Prodeus AP 1998 Linkages of innate and adaptive immunity. Curr Opin Immunol 10:36-40
3. Fearon DT 1998 The complement system and adaptive immunity. Semin Immunol 10:355-361
4. Murphy CR, Rogers PA, Hosie MJ, Leeton J, Beaton L 1992 Tight junctions of human uterine epithelial cells change during the menstrual cycle: a morphometric study. Acta Anat 144:36-38
5. Hasty LA, Lambris JD, Lessey BA, Pruksananonda K, Lyttle CR 1994 Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am J Obstet Gynecol 170:168-175
6. Sayegh RA, Tao XJ, Awwad JT, Isaacson KB 1996 Localization of the expression of complement component 3 in the human endometrium by in situ hybridization. J Clin Endocrinol Metab 81:1641-1649
7. Meri S, Jarva H 1998 Complement regulation. Vox Sang 74:291-302
8. Brooimans RA, van Wieringen PA, van Es LA, Daha MR 1992 Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Eur J Immunol 22:3135-3140
9. Lublin DM, Coyne KE 1991 Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J Exp Med 174:35-44
10. Zhang KZ, Junnikkala S, Erlander MG, Guo H, Westberg JA, Meri S, Anderson LC 1998 Up-regulated expression of decay-accelerating factor (CD55) confers increased complement resistance to sprouting neural cells. Eur J Immunol 28:1189-1196
11. Mason JC, Yarwood H, Sugars K, Morgan BP, Davies KA, Haskard DO 1999 Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition. Blood 94:1673-1682
12. Kaul A, Nagamani M, Nowicki B 1995 Decreased expression of endometrial decay accelerating factor (DAF), a complement regulatory protein, in patients with luteal phase defect. Am J Reprod Immunol 34:236-240
13. Nowicki B, Truong L, Moulds J, Hull R 1988 Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. Am J Pathol 133:1-4
14. Kaul A, Nowicki BJ, Martens MG, Goluszko P, Hart A, Nagamani M, Kumar D, Pham TQ, Nowicki S 1994 Decay-accelerating factor is expressed in the human endometrium and may serve as the attachment ligand for Dr pili of Escherichia coli. Am J Reprod Immunol 32:194-199
15. Kaul AK, Kumar D, Nagamani M, Goluszko P, Nowicki S, Nowicki BJ 1996 Rapid cyclic changes in density and accessibility of endometrial ligands for Escherichia coli Dr fimbriae. Infect Immun 64:611-615
16. Garcia E, Bouchard P, De Brux J, Berdah J, Frydman R, Schaison G, Milgrom E, Perrot-Applanat M 1988 Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab 67:80-87
17. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty Jr KS 1988 Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 67:334-340
18. Koji T, Chedid M, Rubin JS, Slayden OD, Csaky KG, Aaronson SA, Brenner RM 1994 Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin. J Cell Biol 125:393-401
19. Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM, Osteen KG 1995 Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 92:7362-7366
20. Zhang Z, Funk C, Roy D, Glasser S, Mulholland J 1994 Heparin-binding epidermal growth factor-like growth factor is differentially regulated by progesterone and estradiol in rat uterine epithelial and stromal cells. Endocrinology 134:1089-1094
21. Yoo HJ, Barlow DH, Mardon HJ 1997 Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev Genet 21:102-108
22. Leach RE, Khalifa R, Ramirez ND, Das SK, Wang J, Dey SK, Romero R, Armant DR 1999 Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab 84:3355-3363
23. Gui Y, Yuan L, Zhang J, Mulholland J, Lessey B 1999 Is heparin-binding EGF a stromal factor that regulates uterine receptivity? J Soc Gynecol Invest 6:144A
24. Lelle RJ, Talavera F, Gretz H, Roberts JA, Menon KM 1993 Epidermal growth factor receptor expression in three different human endometrial cancer cell lines. Cancer 72:519-525
25. Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD 1983 Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19:147-158
26. Schneider CC, Gibb RK, Taylor DD, Wan T, Gercel-Taylor C 1998 Inhibition of endometrial cancer cell lines by mifepristone (RU 486). J Soc Gynecol Invest 5:334-338
27. Noyes R, Heritg A, Rock J 1950 Dating the endometrial biopsy. Fertil Steril 1:3-25
28. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL, McCarty Jr KS 1986 Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46:5419-5425
29. Coyne KE, Hall SE, Thompson S, Arce MA, Kinoshita T, Fujita T, Anstee DJ, Rosse W, Lublin DM 1992 Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 149:2906-2913
30. Lublin DM, Atkinson JP 1989 Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol 7:35-58
31. Cleveland WS, Devlin SJ 1988 Locally weighted regression: an approach to regression analysis by local fitting. J Am Statist Assoc 83:596-610
32. Tsutakawa RK, Hewett JE 1977 Quick test for comparing two populations with bivariate data. Biometrics 33:215-219
33. Randles RH 1984 On tests applied to residuals. J Am Stat Assoc 79:349-354
34. Kumar S, Vinci JM, Pytel BA, Baglioni C 1993 Expression of messenger RNAs for complement inhibitors in human tissues and tumors. Cancer Res 53:348-353
35. Hackel PO, Zwick E, Prenzel N, Ullrich A 1999 Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11:184-189
36. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H 2000 A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287:498-501
37. Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H, Bamba T 1996 Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human Intestinal epithelial cells. Gastroenterology 111:911-918
38. Gasque P, Morgan BP 1996 Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes. Immunology 89:338-347
39. Moutabarrik A, Nakanishi I, Namiki M, Hara T, Matsumoto M, Ishibashi M, Okuyama A, Zaid D, Seya T 1993 Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells. Lymphokine Cytokine Res 12:167-172
40. Varsano S, Rashkovsky L, Shapiro H, Radnay J 1998 Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines. Am J Respir Cell Mol Biol 19:522-529
41. Kendall G, Crankson H, Ensor E, Lublin DM, Latchman DS 1996 Activation of the gene encoding decay accelerating factor following nerve growth factor treatment of sensory neurons is mediated by promoter sequences within 206 bases of the transcriptional start site. J Neurosci Res 45:96-103